Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myocardial regeneration with bone-marrow-derived stem cells.

Young-Sup Yoon1, Namho Lee, Heather Scadova

  • 1Division of Cardiovascular Research, Caritas St., Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA. young.yoon@tufts.edu

Biology of the Cell
|March 15, 2005
PubMed
Summary

Bone marrow stem cells show promise for repairing heart muscle lost after heart attacks. This review explores current research on stem cell therapy for ischemic cardiomyopathy and its regenerative mechanisms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Establishment and qualification of a GMP-compliant induced pluripotent stem cell master cell bank for clinical applications under the Korean MFDS framework.

Regenerative medicine·2026
Same author

Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trial.

EClinicalMedicine·2026
Same author

Author Correction: Epiblast-derived CX3CR1+ progenitors generate cardiovascular cells during cardiogenesis.

The EMBO journal·2025
Same author

Efficacy and Safety of Rosuvastatin/Amlodipine FDC in Patients With Hypertension and Dyslipidemia: A Multicenter, Prospective, Observational Study.

Clinical therapeutics·2025
Same author

Effectiveness and Safety of CENTUM™, an Everolimus-Eluting Stent, in Patients With Coronary Artery Disease: A Prospective Multi-Center Observational Study.

Korean circulation journal·2025
Same author

Non-integrating direct reprogramming generates therapeutic endothelial cells with sustained vascular regeneration capacity enhanced by nanomatrix delivery.

bioRxiv : the preprint server for biology·2025

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Stem Cell Biology

Background:

  • Heart failure, often caused by ischemic cardiomyopathy and myocardial infarction, leads to irreversible loss of cardiac muscle and vasculature.
  • This loss compromises cardiac integrity and function, remaining a leading cause of mortality.
  • Adult and embryonic stem cells offer potential for tissue repopulation and myocardial regeneration.

Purpose of the Study:

  • To review preclinical and clinical advances in bone marrow-derived stem or progenitor cell therapies for ischemic myocardium repair.
  • To discuss the mechanisms underlying stem cell-mediated myocardial repair and regeneration.

Main Methods:

  • Review of current preclinical and clinical studies on bone marrow-derived stem cell therapies.

Related Experiment Videos

  • Analysis of proposed mechanisms for stem cell-induced myocardial regeneration.

    • Main Results:

    • Stem cell transplantation is being investigated as a novel therapeutic strategy for heart failure.
    • Evidence suggests bone marrow-derived stem and progenitor cells can contribute to myocardial repair.
    • Multiple mechanisms are implicated in the therapeutic effects of these stem cells.

    Conclusions:

    • Bone marrow-derived stem cells represent a promising therapeutic option for ischemic cardiomyopathy.
    • Further research is needed to fully understand their therapeutic potential and underlying mechanisms.
    • Stem cell therapy holds potential for regenerating damaged cardiac tissue and improving heart function.